510(k) K761009
K761009 is an FDA 510(k) premarket notification submitted by Hyland Therapeutic Div., Travenol Laboratories for the device "LYMPHOCYTE TYPING, POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on Apr 6, 1977. The device falls under product code LGO (Test, Leukocyte Typing), a Class I device regulated under 21 CFR 864.7675. Hyland Therapeutic Div., Travenol Laboratories has 43 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 6, 1977
- Date Received
- Nov 2, 1976
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Leukocyte Typing
- Device Class
- Class I
- Regulation Number
- 864.7675
- Review Panel
- HE
- Submission Type
- 510(k) Exempt
Need the full FDA record for Hyland Therapeutic Div., Travenol Laboratories? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.